Pluri Inc. Sale of Stock, Price Per Share
Pluri Inc. (PLUR) had Sale of Stock, Price Per Share of $5.21 per share as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Notes › Equity
us-gaap:SaleOfStockPricePerShare · last filed 2026-05-14
- 2026-03-31: Sale of Stock, Price Per Share $5.21.
- 2025-12-31: Sale of Stock, Price Per Share $5.23.
- 2025-09-30: Sale of Stock, Price Per Share $5.93.
- 2025-06-30: Sale of Stock, Price Per Share $5.93.
| Period end | Sale of Stock, Price Per Share |
|---|---|
| 2026-03-31 | $5.21 10-Q · filed 2026-05-14 |
| 2025-12-31 | $5.23 10-Q · filed 2026-02-12 |
| 2025-09-30 | $5.93 10-Q · filed 2025-11-12 |
| 2025-06-30 | $5.93 10-K · filed 2025-09-17 |
| 2025-03-31 | $5.93 10-Q · filed 2025-05-13 |
| 2024-12-31 | $5.93 10-Q · filed 2025-02-11 |
| 2024-09-30 | $5.93 10-Q · filed 2024-11-12 |
| 2022-12-27 | $1.12 10-K · filed 2023-09-12 |
| 2022-12-19 | $1.09 10-K · filed 2023-09-12 |
| 2022-12-15 | $1.06 10-K · filed 2023-09-12 |
| 2019-06-30 | $12.30 10-K · filed 2019-09-12 |
| 2010-10-18 | $1.20 10-K · filed 2013-09-11 |
| 2010-04-27 | $1.12 10-K · filed 2012-09-10 |
| 2009-10-12 | $1.12 10-K · filed 2012-09-10 |
| 2009-07-31 | $0.75 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |